Vitality Biopharma, Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 3 of 3 Posts
E Interview With Vitality Biopharma Inc.
Article By: InvestInMJ Monday, January 30, 2017 3:00 PM EST
We recently had the pleasure to speak to Robert Brooke, the CEO of Vitality Biopharma, a publicly traded pharmaceutical company focused on cannabis based medical drugs, and their recent R&D breakthrough for those suffering from IBD & Crohn's Disease.
In this article: VBIO Also: LBIO, INO, GWPH
Read
Cannabis Industry Should Benefit From The 21st Century Cures Act
Article By: Jason Napodano Wednesday, December 14, 2016 1:38 PM EST
The cannabis industry should benefit greatly from the passing of the Cures Act. The medical benefits of marijuana, or more specifically, cannabinoids, are real.
In this article: VBIO
Read
Vitality Biopharma Taking Cannabinoid Research To The Next Level
Article By: Jason Napodano Wednesday, November 30, 2016 12:14 PM EST
The medical marijuana and cannabis industry in the U.S. is booming. Vitality Bio is currently conducting preclinical studies in anticipation of filing IND applications in 2017 for glycosylated cannabinoid products called cannabosides.
In this article: VBIO
Read
1 to 3 of 3 Posts